Need help finding what you are looking for?
Contact Us
PUBLISHER: Grand View Research | PRODUCT CODE: 1224606
PUBLISHER: Grand View Research | PRODUCT CODE: 1224606
Exosomes Market Size, Share & Trends Analysis Report By Product (Kits & Reagents, Services), By Application (Cancer, CVD), By Workflow (Isolation Methods, Downstream Analysis), By End-use, And Segment Forecasts, 2023 - 2030
PUBLISHED:
PAGES: 150 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
Exosomes Market Growth & Trends:
The global exosomes market size is projected to reach USD 1.03 billion by 2030, registering a CAGR of 37.75% over the forecast period, according to a new report by Grand View Research, Inc. The major factors driving the market include technological advancements in exosome isolation and analytical procedures, growth in government and non-government initiatives for exosome research, and the increasing prevalence of cancer. For instance, according to the World Health Organization (WHO), in 2020 there were about 10 million deaths due to cancer, making it one of the foremost causes of death worldwide. The industry is anticipated to witness rapid growth, owing to the factors, such as the growing need for the identification of cancer biomarkers, detection of infectious agents, and discovery of treatment options for neurodegenerative & Cardiovascular Diseases (CVDs).
Exosomes released by cells into body fluids display different RNA, protein, and lipid contents in patients with various disease conditions as compared to healthy individuals. Hence, exosomes can be used for the development of diagnostic procedures using biomarker identification. The rising demand for fast, accurate, and minimally invasive diagnostic procedures, thus, represents a promising opportunity for the growth of exosome applications. The COVID-19 pandemic led to the disruption of clinical trials investigating the diagnostic and therapeutic potential of exosomes in 2020. In addition, nationwide lockdown restrictions, disruption of supply chains, and diversion of investments toward COVID-19-related products led to a decrease in the research and development activities involving exosomes.
Despite the adverse impact in 2020, the pandemic has opened up several new prospects for the development of COVID-19 vaccines and treatments with the use of exosomes, which, in turn, is expected to boost industry growth over the coming years. For instance, in March 2021, Cell Guidance Systems, a U.S.-based biotechnology research organization, announced plans for the development of exosome therapeutics for treating COVID-19 disease. Moreover, growth in government and non-government initiatives for exosome research is likely to drive the growth during the study period. For instance, in Jan 2023, Mantra Bio raised funding of USD 9 million to advance the development of its lead-targeted exosome therapeutics program.
Similarly, in February 2021, Evox Therapeutics raised a funding of USD 95.18 million to advance the exosome therapeutics and expand the company's leading exome platform DeliverEX globally. However, stringent regulations pertaining to the approval and commercialization of exosome products may hamper the growth of the industry over the forecast period. In addition, technical difficulties associated with the implementation of exosomes in various applications may hamper the growth during the study period. Some of the major challenges include the lack of efficient transfection strategies and the need for optimization of purification methods. Such, challenges are anticipated to impede the market growth.
Exosomes Market Report Highlights:
- The kits & reagents segment held the largest revenue share in 2022. Isolation of extracellular vesicles can be difficult, non-specific, and a tedious process. Hence, key players are launching innovative kits and reagents to broaden the applications of exosomes, which is fueling the segment growth
- By workflow, the downstream analysis segment accounted for the largest share in 2022. Major players are offering various technologically advanced products for increasing the utility of downstream analyses, which can positively affect the segment growth
- The cancer application segment dominated the market in 2022 due to the broad range of applications of exosomes in cancer diagnosis, prognosis, and treatment
- The pharmaceutical & biotechnology companies end-use led industry in 2022 due to a rise in the R&D activities
- North America was the dominant region in 2022 due to the presence of key players, rising government funding for the detection of new biomarkers, and high incidence of chronic conditions
Product Code: GVR-2-68038-298-3
Table of Contents
Chapter 1 Methodology and Scope
- 1.1 Research Methodology
- 1.2 Research Assumptions
- 1.2.1 Estimates And Forecast Timeline
- 1.3 Information Procurement
- 1.3.1 Purchased Database
- 1.3.2 Gvr's Internal Database
- 1.3.3 Secondary Sources
- 1.3.4 Primary Research
- 1.4 Information Or Data Analysis
- 1.4.1 Data Analysis Models
- 1.5 Market Formulation & Validation
Chapter 2 Executive Summary
- 2.1 Market Snapshot
- 2.2 Segment Snapshot
- 2.3 Competitive Landscape Snapshot
Chapter 3 Market Variables, Trends, & Scope
- 3.1 Parent Market Analysis
- 3.2 Market Dynamics
- 3.2.1 Market Driver Analysis
- 3.2.1.1 Technological Advancements In Exosomes Isolation And Analytical Procedures
- 3.2.1.2 Advanced Applications Of Exosomes
- 3.2.1.3 Growth In Government And Non-Government Initiatives For Exosome Research
- 3.2.1.4 Increasing Prevalence Of Cancer
- 3.2.2 Market Restraint Analysis
- 3.2.2.1 Stringent Regulations Pertaining To Approval
- 3.2.2.1 Challenges Associated With Implementation Of Exosome-Based Therapies
- 3.2.1 Market Driver Analysis
- 3.3 Penetration & Growth Prospect Mapping
- 3.4 Exosomes Market - Porter's Analysis
- 3.5 Exosomes Market - Swot Analysis
- 3.6 Covid-19 Impact Analysis
Chapter 4 Product Business Analysis
- 4.1 Exosomes Market-Product Movement Analysis
- 4.2 Kits & Reagents
- 4.2.1 Global Kits & Reagents Market, 2018 - 2030 (USD Million)
- 4.3 Instruments
- 4.3.1 Global Instruments Market, 2018 - 2030 (USD Million)
- 4.4 Services
- 4.4.1 Global Services Market, 2018 - 2030 (USD Million)
Chapter 5 Workflow Business Analysis
- 5.1 Exosomes Market-Workflow Movement Analysis
- 5.2 Isolation Methods
- 5.2.1 Global Isolation Methods Market, 2018 - 2030 (USD Million)
- 5.2.2 Ultracentrifugation
- 5.2.2.1 Global Ultracentrifugation Market, 2018 - 2030 (USD Million)
- 5.2.3 Immunocapture On Beads
- 5.2.3.1 Global Immunocapture On Beads Market, 2018 - 2030 (USD Million)
- 5.2.4 Precipitation
- 5.2.4.1 Global Precipitation Market, 2018 - 2030 (USD Million)
- 5.2.5 Filtration
- 5.2.5.1 Global Filtration Market, 2018 - 2030 (USD Million)
- 5.2.6 Others
- 5.2.6.1 Global Other Isolation Methods Market, 2018 - 2030 (USD Million)
- 5.3 Downstream Analysis
- 5.3.1 Global Downstream Analysis Market, 2018 - 2030 (USD Million)
- 5.3.2 Cell Surface Marker Analysis Using Flow Cytometry
- 5.3.2.1 Global Cell Surface Marker Analysis Using Flow Cytometry Market, 2018 - 2030 (USD Million)
- 5.3.3 Protein Analysis Using Blotting & Elisa
- 5.3.3.1 Global Protein Analysis Using Blotting & Elisa Market, 2018 - 2030 (USD Million)
- 5.3.4 Rna Analysis With Ngs & Pcr
- 5.3.4.1 Global Rna Analysis With Ngs & Pcr Market, 2018 - 2030 (USD Million)
- 5.3.5 Proteomic Analysis Using Mass Spectrometry
- 5.3.5.1 Global Proteomic Analysis Using Mass Spectrometry Market, 2018 - 2030 (USD Million)
- 5.3.6 Others
- 5.3.6.1 Global Other Downstream Analysis Market, 2018 - 2030 (USD Million)
Chapter 6 Application Business Analysis
- 6.1 Exosomes Market-Application Movement Analysis
- 6.2 Cancer
- 6.2.1 Global Cancer Market, 2018 - 2030 (USD Million)
- 6.3 Nurodegenrative Diseases
- 6.3.1 Global Nurodegenerative Diseases Market, 2018 - 2030 (USD Million)
- 6.4 Cardiovascular Diseases
- 6.4.1 Global Cardiovascular Diseases Market, 2018 - 2030 (USD Million)
- 6.5 Infectious Diseases
- 6.5.1 Global Infectious Diseases Market, 2018 - 2030 (USD Million)
- 6.6 Others
- 6.6.1 Global Other Applications Market, 2018 - 2030 (USD Million)
Chapter 7 End-Use Business Analysis
- 7.1 Exosomes Market-End-Use Movement Analysis
- 7.2 Pharmaceutical & Biotechnology Companies
- 7.2.1 Global Pharmaceutical & Biotechnology Companies Market, 2018 - 2030 (USD Million)
- 7.3 Hospitals & Diagnostics Centers
- 7.3.1 Global Hospitals & Diagnostics Centers Market, 2018 - 2030 (USD Million)
- 7.4 Academic & Research Institutes
- 7.4.1 Global Academic & Research Institutes Market, 2018 - 2030 (USD Million)
Chapter 8 Regional Business Analysis
- 8.1 Exosomes Market: Regional Movement Analysis
- 8.2 North America
- 8.2.1 Swot Analysis
- 8.2.1.1 North America Exosome Market, 2018 - 2030 (USD Million)
- 8.2.2 U.S.
- 8.2.2.1 Key Country Dynamics
- 8.2.2.2 Competitive Scenario
- 8.2.2.3 U.S. Exosome Market, 2018 - 2030 (USD Million)
- 8.2.3 Canada
- 8.2.3.1 Key Country Dynamics
- 8.2.3.2 Competitive Scenario
- 8.2.3.3 Canada Exosome Market, 2018 - 2030 (USD Million)
- 8.2.1 Swot Analysis
- 8.3 Europe
- 8.3.1 Swot Analysis
- 8.3.1.1 Europe Exosome Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 8.3.2 U.K.
- 8.3.2.1 Key Country Dynamics
- 8.3.2.2 Competitive Scenario
- 8.3.2.3 U.K. Exosome Market, 2018 - 2030 (USD Million)
- 8.3.3 Germany
- 8.3.3.1 Key Country Dynamics
- 8.3.3.2 Competitive Scenario
- 8.3.3.3 Germany Exosome Market, 2018 - 2030 (USD Million)
- 8.3.4 France
- 8.3.4.1 Key Country Dynamics
- 8.3.4.2 Competitive Scenario
- 8.3.4.3 France Exosome Market, 2018 - 2030 (USD Million)
- 8.3.5 Italy
- 8.3.5.1 Key Country Dynamics
- 8.3.5.2 Competitive Scenario
- 8.3.5.3 Italy Exosome Market, 2018 - 2030 (USD Million)
- 8.3.6 Spain
- 8.3.6.1 Key Country Dynamics
- 8.3.6.2 Competitive Scenario
- 8.3.6.3 Spain Exosome Market, 2018 - 2030 (USD Million)
- 8.3.7 Denmark
- 8.3.7.1 Key Country Dynamics
- 8.3.7.2 Competitive Scenario
- 8.3.7.3 Denmark Exosome Market, 2018 - 2030 (USD Million)
- 8.3.8 Sweden
- 8.3.8.1 Key Country Dynamics
- 8.3.8.2 Competitive Scenario
- 8.3.8.3 Sweden Exosome Market, 2018 - 2030 (USD Million)
- 8.3.9 Norway
- 8.3.9.1 Key Country Dynamics
- 8.3.9.2 Competitive Scenario
- 8.3.9.3 Norway Exosome Market, 2018 - 2030 (USD Million)
- 8.3.1 Swot Analysis
- 8.4 Asia Pacific
- 8.4.1 Swot Analysis
- 8.4.1.1 Asia Pacific Vacuum Blood Collection Tube, 2018 - 2030 (USD Million)
- 8.4.2 Japan
- 8.4.2.1 Key Country Dynamics
- 8.4.2.2 Competitive Scenario
- 8.4.2.3 Japan Exosome Market, 2018 - 2030 (USD Million)
- 8.4.3 China
- 8.4.3.1 Key Country Dynamics
- 8.4.3.2 Competitive Scenario
- 8.4.3.3 China Exosome Market, 2018 - 2030 (USD Million)
- 8.4.4 India
- 8.4.4.1 Key Country Dynamics
- 8.4.4.2 Competitive Scenario
- 8.4.4.3 India Exosome Market, 2018 - 2030 (USD Million)
- 8.4.5 Australia
- 8.4.5.1 Key Country Dynamics
- 8.4.5.2 Competitive Scenario
- 8.4.5.3 Australia Exosome Market, 2018 - 2030 (USD Million)
- 8.4.6 Thailand
- 8.4.6.1 Key Country Dynamics
- 8.4.6.2 Competitive Scenario
- 8.4.6.3 Thailand Exosome Market, 2018 - 2030 (USD Million)
- 8.4.7 South Korea
- 8.4.7.1 Key Country Dynamics
- 8.4.7.2 Competitive Scenario
- 8.4.7.3 South Korea Exosome Market, 2018 - 2030 (USD Million)
- 8.4.8 Singapore
- 8.4.8.1 Key Country Dynamics
- 8.4.8.2 Competitive Scenario
- 8.4.8.3 Singapore Exosome Market, 2018 - 2030 (USD Million)
- 8.4.1 Swot Analysis
- 8.5 Latin America
- 8.5.1 Swot Analysis
- 8.5.1.1 Latin America Exosome Market, 2018 - 2030 (USD Million)
- 8.5.2 Brazil
- 8.5.2.1 Key Country Dynamics
- 8.5.2.2 Competitive Scenario
- 8.5.2.3 Brazil Exosome Market, 2018 - 2030 (USD Million)
- 8.5.3 Mexico
- 8.5.3.1 Key Country Dynamics
- 8.5.3.2 Competitive Scenario
- 8.5.3.3 Mexico Exosome Market, 2018 - 2030 (USD Million)
- 8.5.4 Argentina
- 8.5.4.1 Key Country Dynamics
- 8.5.4.2 Competitive Scenario
- 8.5.4.3 Argentina Exosome Market, 2018 - 2030 (USD Million)
- 8.5.1 Swot Analysis
- 8.6 Middle East & Africa (Mea)
- 8.6.1 Swot Analysis
- 8.6.1.1 Mea Exosome Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 8.6.2 South Africa
- 8.6.2.1 Key Country Dynamics
- 8.6.2.2 Competitive Scenario
- 8.6.2.3 South Africa Exosome Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 8.6.3 Saudi Arabia
- 8.6.3.1 Key Country Dynamics
- 8.6.3.2 Competitive Scenario
- 8.6.3.3 Saudi Arabia Exosome Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 8.6.4 Uae
- 8.6.4.1 Key Country Dynamics
- 8.6.4.2 Competitive Scenario
- 8.6.4.3 Uae Exosome Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 8.6.5 Kuwait
- 8.6.5.1 Key Country Dynamics
- 8.6.5.2 Competitive Scenario
- 8.6.5.3 Kuwait Exosome Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 8.6.1 Swot Analysis
Chapter 9 Competitive Landscape
- 9.1 Participant's Overview
- 9.1.1 Danaher Corporation
- 9.1.2 Hologic Inc.
- 9.1.3 Fujifilm Holdings Corporation
- 9.1.4 Lonza
- 9.1.5 Miltenyi Biotec
- 9.1.6 Bio-Techne Corporation
- 9.1.7 Qiagen
- 9.1.8 Thermo Fisher Scientific, Inc
- 9.1.9 Abcam Plc
- 9.1.10 Roosterbio, Inc.
- 9.2 Financial Performance
- 9.3 Participant Categorization
- 9.3.1 Market Leaders
- 9.3.1.1 Exosomes Market Share Analysis, 2022
- 9.3.2 Strategy Mapping
- 9.3.2.1 Expansion
- 9.3.2.2 Acquisition
- 9.3.2.3 Collaborations
- 9.3.2.4 Product/Service Launch
- 9.3.2.5 Partnerships
- 9.3.2.6 Others
- 9.3.1 Market Leaders
Product Code: GVR-2-68038-298-3
List of Tables
- Table 1 List of secondary sources
- Table 2 List of abbreviations
- Table 3 Global exosomes market, by product, 2018 - 2030 (USD Million)
- Table 4 Global exosomes market, by workflow, 2018 - 2030 (USD Million)
- Table 5 Global exosomes market, by application, 2018 - 2030 (USD Million)
- Table 6 Global exosomes market, by end-use, 2018 - 2030 (USD Million)
- Table 7 Global exosomes market, by region, 2018 - 2030 (USD Million)
- Table 8 North America exosomes market, by country, 2018 - 2030 (USD Million)
- Table 9 North America exosomes market, by product, 2018 - 2030 (USD Million)
- Table 10 North America exosomes market, by workflow, 2018 - 2030 (USD Million)
- Table 11 North America exosomes market, by application, 2018 - 2030 (USD Million)
- Table 12 North America exosomes market, by end-use, 2018 - 2030 (USD Million)
- Table 13 U.S. exosomes market, by product, 2018 - 2030 (USD Million)
- Table 14 U.S. exosomes market, by workflow, 2018 - 2030 (USD Million)
- Table 15 U.S. exosomes market, by application, 2018 - 2030 (USD Million)
- Table 16 U.S. exosomes market, by end-use, 2018 - 2030 (USD Million)
- Table 17 Canada exosomes market, by product, 2018 - 2030 (USD Million)
- Table 18 Canada exosomes market, by workflow, 2018 - 2030 (USD Million)
- Table 19 Canada exosomes market, by application, 2018 - 2030 (USD Million)
- Table 20 Canada exosomes market, by end-use, 2018 - 2030 (USD Million)
- Table 21 Europe exosomes market, by country, 2018 - 2030 (USD Million)
- Table 22 Europe exosomes market, by product, 2018 - 2030 (USD Million)
- Table 23 Europe exosomes market, by workflow, 2018 - 2030 (USD Million)
- Table 24 Europe exosomes market, by application, 2018 - 2030 (USD Million)
- Table 25 Europe exosomes market, by end-use, 2018 - 2030 (USD Million)
- Table 26 U.K. exosomes market, by product, 2018 - 2030 (USD Million)
- Table 27 U.K. exosomes market, by workflow, 2018 - 2030 (USD Million)
- Table 28 U.K. exosomes market, by application, 2018 - 2030 (USD Million)
- Table 29 U.K. exosomes market, by end-use, 2018 - 2030 (USD Million)
- Table 30 Germany exosomes market, by product, 2018 - 2030 (USD Million)
- Table 31 Germany exosomes market, by workflow, 2018 - 2030 (USD Million)
- Table 32 Germany exosomes market, by application, 2018 - 2030 (USD Million)
- Table 33 Germany exosomes market, by end-use, 2018 - 2030 (USD Million)
- Table 34 France exosomes market, by product, 2018 - 2030 (USD Million)
- Table 35 France exosomes market, by workflow, 2018 - 2030 (USD Million)
- Table 36 France exosomes market, by application, 2018 - 2030 (USD Million)
- Table 37 France exosomes market, by end-use, 2018 - 2030 (USD Million)
- Table 38 Italy exosomes market, by product, 2018 - 2030 (USD Million)
- Table 39 Italy exosomes market, by workflow, 2018 - 2030 (USD Million)
- Table 40 Italy exosomes market, by application, 2018 - 2030 (USD Million)
- Table 41 Italy exosomes market, by end-use, 2018 - 2030 (USD Million)
- Table 42 Spain exosomes market, by product, 2018 - 2030 (USD Million)
- Table 43 Spain exosomes market, by workflow, 2018 - 2030 (USD Million)
- Table 44 Spain exosomes market, by application, 2018 - 2030 (USD Million)
- Table 45 Spain exosomes market, by end-use, 2018 - 2030 (USD Million)
- Table 46 Denmark exosomes market, by product, 2018 - 2030 (USD Million)
- Table 47 Denmark exosomes market, by workflow, 2018 - 2030 (USD Million)
- Table 48 Denmark exosomes market, by application, 2018 - 2030 (USD Million)
- Table 49 Denmark exosomes market, by end-use, 2018 - 2030 (USD Million)
- Table 50 Sweden exosomes market, by product, 2018 - 2030 (USD Million)
- Table 51 Sweden exosomes market, by workflow, 2018 - 2030 (USD Million)
- Table 52 Sweden exosomes market, by application, 2018 - 2030 (USD Million)
- Table 53 Sweden exosomes market, by end-use, 2018 - 2030 (USD Million)
- Table 54 Norway exosomes market, by product, 2018 - 2030 (USD Million)
- Table 55 Norway exosomes market, by workflow, 2018 - 2030 (USD Million)
- Table 56 Norway exosomes market, by application, 2018 - 2030 (USD Million)
- Table 57 Norway exosomes market, by end-use, 2018 - 2030 (USD Million)
- Table 58 Asia Pacific exosomes market, by country, 2018 - 2030 (USD Million)
- Table 59 Asia Pacific exosomes market, by product, 2018 - 2030 (USD Million)
- Table 60 Asia Pacific exosomes market, by workflow, 2018 - 2030 (USD Million)
- Table 61 Asia Pacific exosomes market, by application, 2018 - 2030 (USD Million)
- Table 62 Asia Pacific exosomes market, by end-use, 2018 - 2030 (USD Million)
- Table 63 Japan exosomes market, by product, 2018 - 2030 (USD Million)
- Table 64 Japan exosomes market, by workflow, 2018 - 2030 (USD Million)
- Table 65 Japan exosomes market, by application, 2018 - 2030 (USD Million)
- Table 66 Japan exosomes market, by end-use, 2018 - 2030 (USD Million)
- Table 67 China exosomes market, by product, 2018 - 2030 (USD Million)
- Table 68 China exosomes market, by workflow, 2018 - 2030 (USD Million)
- Table 69 China exosomes market, by application, 2018 - 2030 (USD Million)
- Table 70 China exosomes market, by end-use, 2018 - 2030 (USD Million)
- Table 71 India exosomes market, by product, 2018 - 2030 (USD Million)
- Table 72 India exosomes market, by workflow, 2018 - 2030 (USD Million)
- Table 73 India exosomes market, by application, 2018 - 2030 (USD Million)
- Table 74 India exosomes market, by end-use, 2018 - 2030 (USD Million)
- Table 75 Australia exosomes market, by product, 2018 - 2030 (USD Million)
- Table 76 Australia exosomes market, by workflow, 2018 - 2030 (USD Million)
- Table 77 Australia exosomes market, by application, 2018 - 2030 (USD Million)
- Table 78 Australia exosomes market, by end-use, 2018 - 2030 (USD Million)
- Table 79 Thailand exosomes market, by product, 2018 - 2030 (USD Million)
- Table 80 Thailand exosomes market, by workflow, 2018 - 2030 (USD Million)
- Table 81 Thailand exosomes market, by application, 2018 - 2030 (USD Million)
- Table 82 Thailand exosomes market, by end-use, 2018 - 2030 (USD Million)
- Table 83 South Korea exosomes market, by product, 2018 - 2030 (USD Million)
- Table 84 South Korea exosomes market, by workflow, 2018 - 2030 (USD Million)
- Table 85 South Korea exosomes market, by application, 2018 - 2030 (USD Million)
- Table 86 South Korea exosomes market, by end-use, 2018 - 2030 (USD Million)
- Table 87 Singapore exosomes market, by product, 2018 - 2030 (USD Million)
- Table 88 Singapore exosomes market, by workflow, 2018 - 2030 (USD Million)
- Table 89 Singapore exosomes market, by application, 2018 - 2030 (USD Million)
- Table 90 Singapore exosomes market, by end-use, 2018 - 2030 (USD Million)
- Table 91 Latin America exosomes market, by country, 2018 - 2030 (USD Million)
- Table 92 Latin America exosomes market, by product, 2018 - 2030 (USD Million)
- Table 93 Latin America exosomes market, by workflow, 2018 - 2030 (USD Million)
- Table 94 Latin America exosomes market, by application, 2018 - 2030 (USD Million)
- Table 95 Latin America exosomes market, by end-use, 2018 - 2030 (USD Million)
- Table 96 Brazil exosomes market, by product, 2018 - 2030 (USD Million)
- Table 97 Brazil exosomes market, by workflow, 2018 - 2030 (USD Million)
- Table 98 Brazil exosomes market, by application, 2018 - 2030 (USD Million)
- Table 99 Brazil exosomes market, by end-use, 2018 - 2030 (USD Million)
- Table 100 Mexico exosomes market, by product, 2018 - 2030 (USD Million)
- Table 101 Mexico exosomes market, by workflow, 2018 - 2030 (USD Million)
- Table 102 Mexico exosomes market, by application, 2018 - 2030 (USD Million)
- Table 103 Mexico exosomes market, by end-use, 2018 - 2030 (USD Million)
- Table 104 Argentina exosomes market, by product, 2018 - 2030 (USD Million)
- Table 105 Argentina exosomes market, by workflow, 2018 - 2030 (USD Million)
- Table 106 Argentina exosomes market, by application, 2018 - 2030 (USD Million)
- Table 107 Argentina exosomes market, by end-use, 2018 - 2030 (USD Million)
- Table 108 Middle East & Africa exosomes market, by country, 2018 - 2030 (USD Million)
- Table 109 Middle East & Africa exosomes market, by product, 2018 - 2030 (USD Million)
- Table 110 Middle East & Africa exosomes market, by workflow, 2018 - 2030 (USD Million)
- Table 111 Middle East & Africa exosomes market, by application, 2018 - 2030 (USD Million)
- Table 112 Middle East & Africa exosomes market, by end-use, 2018 - 2030 (USD Million)
- Table 113 South Africa exosomes market, by product, 2018 - 2030 (USD Million)
- Table 114 South Africa exosomes market, by workflow, 2018 - 2030 (USD Million)
- Table 115 South Africa exosomes market, by application, 2018 - 2030 (USD Million)
- Table 116 South Africa exosomes market, by end-use, 2018 - 2030 (USD Million)
- Table 117 Saudi Arabia exosomes market, by product, 2018 - 2030 (USD Million)
- Table 118 Saudi Arabia exosomes market, by workflow, 2018 - 2030 (USD Million)
- Table 119 Saudi Arabia exosomes market, by application, 2018 - 2030 (USD Million)
- Table 120 Saudi Arabia exosomes market, by end-use, 2018 - 2030 (USD Million)
- Table 121 UAE exosomes market, by product, 2018 - 2030 (USD Million)
- Table 122 UAE exosomes market, by workflow, 2018 - 2030 (USD Million)
- Table 123 UAE exosomes market, by application, 2018 - 2030 (USD Million)
- Table 124 UAE exosomes market, by end-use, 2018 - 2030 (USD Million)
- Table 125 Kuwait exosomes market, by product, 2018 - 2030 (USD Million)
- Table 126 Kuwait exosomes market, by workflow, 2018 - 2030 (USD Million)
- Table 127 Kuwait exosomes market, by application, 2018 - 2030 (USD Million)
- Table 128 Kuwait exosomes market, by end-use, 2018 - 2030 (USD Million)
- Table 129 Participant's overview
- Table 130 Financial performance
- Table 131 Key companies undergoing expansions
- Table 132 Key companies undergoing acquisitions
- Table 133 Key companies undergoing collaborations
- Table 134 Key companies launching new products/services
- Table 135 Key companies undergoing partnerships
- Table 136 Key companies undertaking other strategies
List of Figures
- Fig. 1 Market research process
- Fig. 2 Data triangulation techniques
- Fig. 3 Primary research pattern
- Fig. 4 Market research approaches
- Fig. 5 Value-chain-based sizing & forecasting
- Fig. 6 QFD modeling for market share assessment
- Fig. 7 Market formulation & validation
- Fig. 8 Market summary, 2022 (USD Million)
- Fig. 9 Market segmentation & scope
- Fig. 10 Market driver impact
- Fig. 11 Market restraint impact
- Fig. 12 Penetration & growth prospect mapping
- Fig. 13 Porter's analysis
- Fig. 14 SWOT analysis
- Fig. 15 Exosome market: Product outlook and key takeaways
- Fig. 16 Exosome market: Product movement analysis
- Fig. 17 Global kits & reagents market, 2018 - 2030 (USD Million)
- Fig. 18 Global instruments market, 2018 - 2030 (USD Million)
- Fig. 19 Global services market, 2018 - 2030 (USD Million)
- Fig. 20 Exosome market: Workflow outlook and key takeaways
- Fig. 21 Exosome market: Workflow movement analysis
- Fig. 22 Global isolation methods market, 2018 - 2030 (USD Million)
- Fig. 23 Global ultracentrifugation market, 2018 - 2030 (USD Million)
- Fig. 24 Global immunocapture on beads market, 2018 - 2030 (USD Million)
- Fig. 25 Global precipitation market, 2018 - 2030 (USD Million)
- Fig. 26 Global filtration market, 2018 - 2030 (USD Million)
- Fig. 27 Global other isolation methods market, 2018 - 2030 (USD Million)
- Fig. 28 Global downstream analysis market, 2018 - 2030 (USD Million)
- Fig. 29 Global cell surface marker analysis using flow cytometry market, 2018 - 2030 (USD Million)
- Fig. 30 Global protein analysis using blotting & ELISA market, 2018 - 2030 (USD Million)
- Fig. 31 Global RNA analysis with NGS & PCR market, 2018 - 2030 (USD Million)
- Fig. 32 Global proteomic analysis using mass spectroscopy market, 2018 - 2030 (USD Million)
- Fig. 33 Global other downstream analysis market, 2018 - 2030 (USD Million)
- Fig. 34 Exosome market: Application outlook and key takeaways
- Fig. 35 Exosome market: Application movement analysis
- Fig. 36 Global cancer market, 2018 - 2030 (USD Million)
- Fig. 37 Global neurodegenerative diseases market, 2018 - 2030 (USD Million)
- Fig. 38 Global cardiovascular diseases market, 2018 - 2030 (USD Million)
- Fig. 39 Global infectious diseases market, 2018 - 2030 (USD Million)
- Fig. 40 Global other applications market, 2018 - 2030 (USD Million)
- Fig. 41 Exosome market: End-use outlook and key takeaways
- Fig. 42 Exosome market: End-use movement analysis
- Fig. 43 Global pharmaceutical & biotechnology companies market, 2018 - 2030 (USD Million)
- Fig. 44 Global hospitals & diagnostics centers market, 2018 - 2030 (USD Million)
- Fig. 45 Global academic & research institutes market, 2018 - 2030 (USD Million)
- Fig. 46 Exosome market: Regional outlook and key takeaways
- Fig. 47 North America: SWOT Analysis
- Fig. 48 North America exosome market, 2018 - 2030 (USD Million)
- Fig. 49 U.S. key country dynamics
- Fig. 50 U.S. exosome market, 2018 - 2030 (USD Million)
- Fig. 51 Canada key country dynamics
- Fig. 52 Canada exosome market, 2018 - 2030 (USD Million)
- Fig. 53 Europe: SWOT Analysis
- Fig. 54 Europe exosome market estimates and forecast, 2018 - 2030 (USD Million)
- Fig. 55 U.K. key country dynamics
- Fig. 56 U.K. exosome market estimates and forecast, 2018 - 2030 (USD Million)
- Fig. 57 Germany key country dynamics
- Fig. 58 Germany exosome market estimates and forecast, 2018 - 2030 (USD Million)
- Fig. 59 France key country dynamics
- Fig. 60 France exosome market estimates and forecast, 2018 - 2030 (USD Million)
- Fig. 61 Italy key country dynamics
- Fig. 62 Italy exosome market estimates and forecast, 2018 - 2030 (USD Million)
- Fig. 63 Spain key country dynamics
- Fig. 64 Spain exosome market estimates and forecast, 2018 - 2030 (USD Million)
- Fig. 65 Denmark key country dynamics
- Fig. 66 Denmark exosome market estimates and forecast, 2018 - 2030 (USD Million)
- Fig. 67 Sweden key country dynamics
- Fig. 68 Sweden exosome market estimates and forecast, 2018 - 2030 (USD Million)
- Fig. 69 Norway key country dynamics
- Fig. 70 Norway exosome market estimates and forecast, 2018 - 2030 (USD Million)
- Fig. 71 Rest of Europe key country dynamics
- Fig. 72 Rest of Europe exosome market estimates and forecast, 2018 - 2030 (USD Million)
- Fig. 73 Asia-Pacific: SWOT Analysis
- Fig. 74 Asia-Pacific exosome market estimates and forecast, 2018 - 2030 (USD Million)
- Fig. 75 Japan key country dynamics
- Fig. 76 Japan exosome market estimates and forecast, 2018 - 2030 (USD Million)
- Fig. 77 China key country dynamics
- Fig. 78 China exosome market estimates and forecast, 2018 - 2030 (USD Million)
- Fig. 79 India key country dynamics
- Fig. 80 India exosome market estimates and forecast, 2018 - 2030 (USD Million)
- Fig. 81 Australia key country dynamics
- Fig. 82 Australia exosome market estimates and forecast, 2018 - 2030 (USD Million)
- Fig. 83 Thailand key country dynamics
- Fig. 84 Thailand exosome market estimates and forecast, 2018 - 2030 (USD Million)
- Fig. 85 South Korea key country dynamics
- Fig. 86 South Korea exosome market estimates and forecast, 2018 - 2030 (USD Million)
- Fig. 87 Singapore key country dynamics
- Fig. 88 Singapore exosome market estimates and forecast, 2018 - 2030 (USD Million)
- Fig. 89 Rest of APAC key country dynamics
- Fig. 90 Rest of APAC exosome market estimates and forecast, 2018 - 2030 (USD Million)
- Fig. 91 Latin America: SWOT Analysis
- Fig. 92 Latin America exosome market estimates and forecast, 2018 - 2030 (USD Million)
- Fig. 93 Brazil key country dynamics
- Fig. 94 Brazil exosome market estimates and forecast, 2018 - 2030 (USD Million)
- Fig. 95 Mexico key country dynamics
- Fig. 96 Mexico exosome market estimates and forecast, 2018 - 2030 (USD Million)
- Fig. 97 Argentina key country dynamics
- Fig. 98 Argentina exosome market estimates and forecast, 2018 - 2030 (USD Million)
- Fig. 99 Rest of LATAM key country dynamics
- Fig. 100 Rest of LATAM exosome market estimates and forecast, 2018 - 2030 (USD Million)
- Fig. 101 MEA: SWOT Analysis
- Fig. 102 MEA exosome market estimates and forecast, 2018 - 2030 (USD Million)
- Fig. 103 South Africa key country dynamics
- Fig. 104 South Africa exosome market estimates and forecast, 2018 - 2030 (USD Million)
- Fig. 105 Saudi Arabia key country dynamics
- Fig. 106 Saudi Arabia exosome market estimates and forecast, 2018 - 2030 (USD Million)
- Fig. 107 UAE key country dynamics
- Fig. 108 UAE exosome market estimates and forecast, 2018 - 2030 (USD Million)
- Fig. 109 Kuwait key country dynamics
- Fig. 110 Kuwait exosome market estimates and forecast, 2018 - 2030 (USD Million)
- Fig. 111 Rest of MEA key country dynamics
- Fig. 112 Rest of MEA exosome market estimates and forecast, 2018 - 2030 (USD Million)
- Fig. 113 Heat map analysis
- Fig. 114 Market participant categorization
- Fig. 115 Exosomes market share analysis, 2022
- Fig. 116 Strategy framework
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.